---
company: Functional Brands Inc.
ticker: MEHA
form: 8-K
filed: 2026-05-18
accession: 0001213900-26-058120
source: https://www.sec.gov/Archives/edgar/data/1837254/000121390026058120/
---

# Functional Brands (MEHA) earnings release, May 18, 2026

Functional Brands Inc. (MEHA) · Form 8-K, Item 2.02 · Filed 2026-05-18 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1837254/000121390026058120/)

Functional Brands Announces First Quarter 2026

Financial Results

Lake Oswego, OR – (May 18, 2026) – Functional Brands

Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced financial results for the first quarter ended March 31, 2026.

First Quarter 2026 Financial Highlights

Strategic Highlights

“Our recent results reflect important strategic and operational progress, including revenue growth, a 390 basis point expansion of gross margin, and the completion of a simplification of our capital structure,” said Eric Gripentrog, CEO of Functional Brands Inc. “Over the past several months, we’ve executed a series of key initiatives that mark a pivotal period in the Company’s evolution and establish a strong foundation for sustainable, profitable growth.”

Financial Results for the Quarter Ended March 31, 2026:

Revenue

Net revenue for the three months ended March 31, 2026 was $1,645,524 compared to $1,590,256 for the three months ended March 31, 2025 representing an increase of approximately 3.5%. This increase of

$55,268 in net revenue was primarily due to the increase in the demand from our direct-to-consumer sales channel.

Gross profit

Gross profit for the three months ended March 31, 2026 was $961,133 compared to 866,764 representing an increase of 11%. This increase of $94,369 was primarily due to the increase in demand from direct-to-consumer sales channel and operational efficiencies. Gross profit margin increased 390 basis points to 58.4%, driven by continued focus on higher margin channels.

Sales and marketing expenses

Sales and marketing expenses for the three months ended March 31, 2026, was $263,707 compared to $178,630 for the three months ended March 31, 2025, representing an increase of approximately 48%. This increase of $85,077 was primarily due to the increase in amazon referral fees and commissions moving from a wholesaler model to a Direct Seller’s

Central model.

General and administrative expenses

General and administrative expenses for the three months ended March 31, 2026 was $1,380,231, compared to $720,234 for the three months ended March 31, 2025, representing an increase of approximately 92%.

This increase of $659,997 was primarily attributable to an increase professional fees and payroll.

Other income / (expenses)

Other income /expense for the three months ended March 31, 2026 was a negative $6,307,984 compared to a negative of $94,682 for the three months ended March 31, 2025. This increase of $6,213,302 was primarily due to the loss on issuance of preferred stock of $6,310,464, a reduction in interest expense of $69,290, and a change of fair value of derivative liability of $25,374.

About Functional Brands Inc.

Functional Brands Inc. (NASDAQ: MEHA) is a leading innovator in wellness and performance products dedicated to Making Everyone Healthy Again™. The Company’s portfolio includes

Kirkman®, one of the most trusted names in nutritional supplements for over 75 years with products available in more than

35 countries; P2i™ by Kirkman®

Prenatal Multivitamin & Multimineral, the first prenatal supplement to align with FIGO standards and comply with California SB 646; and Tru2u.health, a consumer-facing telehealth and wellness platform. Functional

Brands operates an FDA-registered, cGMP-compliant manufacturing facility in Oregon. For more information, visit www.functionalbrandsinc.com, www.kirkmangroup.com, or www.tru2u.health.

For more information, visit www.functionalbrandsinc.com and www.kirkmangroup.com, and www.Tru2u.health²

Investor Relations Contact:

FunctionalBrands@icrinc.com

Cautionary Note Regarding Forward Looking Statements

This news release and statements of Functional Brands’ management in connection with this news release or related events contain or may contain “forward-looking statements” within the meaning of

Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects,” “anticipates,” “intends,” “plans,” “believes,”

“potential,” “will,” “should,” “could,” “would,” “optimistic” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control.

Important factors that may cause actual results and outcomes to differ materially from those contained in such forward-looking statements include, without limitation, the ability of the parties to negotiate final terms of a definitive acquisition agreement, the closing of the contemplated asset purchase agreement, including expected conditions to closing which are anticipated to include regulatory approvals, valuations, and future shareholder approvals; the occurrence of any event, change or other circumstances that could give rise to the right of one or both of the Company or BullionFX (collectively, the “LOI

Parties”) to terminate the LOI agreement; the effect of such termination; the outcome of any legal proceedings that may be instituted against LOI Parties or their respective directors or officers; the ability to obtain regulatory and other approvals and meet other closing... (truncated)tory and other approvals required may not obtained on a timely basis or at all, or are obtained subject to conditions that are not anticipated or that could adversely affect the combined company or the expected benefits of the transaction; the ability to obtain any necessary approval by the Company’s stockholders on the expected schedule of the transactions contemplated by the LOI; difficulties and delays in integrating BullionFX’s assets in the Company; prevailing economic, market, regulatory or business conditions, or changes in such conditions, negatively affecting the parties; potential adverse reactions or changes to business relationships resulting from the announcement of the LOI and future expected acquisition; uncertainty as to the long-term value of the common stock of the Company following the acquisition; the significant dilution to the Company’s stockholder in connection with the acquisition; the continued availability of capital and financing following the potential acquisition transaction; the business, economic and political conditions in the markets in which the LOI Parties operate; and the fact that the Company’s reported earnings and financial position may be adversely affected by tax and other factors.

Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Functional Brands’ Registration Statement filed with the SEC on Form S-1 on October 16, 2025 and the Company’s Annual Report on Form 10-K filed with the SEC on March 27,

2026 for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov.

Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.³

## Financial statements

### Income Statement (Three Months Ended — (In U.S. dollars, except share data or otherwise noted))

| | Three Months Ended – March 31, – 2026 | Three Months Ended – March 31, – 2025 |
|---|---:|---:|
| Revenue, net of returns | 1,645,524 | 1,590,256 |
| Cost of goods sold | 684,391 | 723,492 |
| Gross profit | 961,133 | 866,764 |
| Operating expenses | Sales and marketing | 263,707 | 178,630 |
| Operating expenses | General and administrative | 1,380,231 | 720,234 |
| Operating expenses | Total operating expenses | 1,643,938 | 898,864 |
| Operating expenses | Operating loss | -682,805 | -32,100 |
| Other income / (expense) | Interest income | 2,910 | 299 |
| Other income / (expense) | Other income |  | 113 |
| Other income / (expense) | Interest expense | -25,804 | -95,094 |
| Other income / (expense) | Change in fair value of derivative liabilities | 25,374 |  |
| Other income / (expense) | Loss on issuance of preferred stock | -6,310,464 |  |
| Other income / (expense) | Total other income / (expense) | -6,307,984 | -94,682 |
| Other income / (expense) | Net loss | -6,990,789 | -126,782 |
| Other income / (expense) | Basic | -0.36 | -0.02 |
| Other income / (expense) | Diluted | -0.36 | -0.02 |
| Weighted average shares used in computing net loss per share of common stock | Basic | 19,594,102 | 6,917,226 |
| Weighted average shares used in computing net loss per share of common stock | Diluted | 19,594,102 | 6,917,226 |

### Balance Sheet (December 31, — (In U.S. dollars, except share data or otherwise noted))

| | March 31, – 2026 | December 31, – 2025 |
|---|---:|---:|
| Current assets: | Cash | 1,077,967 | 2,726,696 |
| Current assets: | Accounts receivable, net | 372,712 | 518,474 |
| Current assets: | Inventories, net | 1,591,548 | 1,549,511 |
| Current assets: | Prepaid expenses and other current assets | 355,096 | 392,999 |
| Current assets: | Total current assets | 3,397,323 | 5,187,680 |
| Noncurrent assets: | Property and equipment, net | 32,797 | 37,379 |
| Noncurrent assets: | Right-of-use assets, net | 1,579,814 | 1,667,693 |
| Noncurrent assets: | Intangible assets, net | 1,385,879 | 1,397,411 |
| Noncurrent assets: | Goodwill | 818,139 | 818,139 |
| Noncurrent assets: | Total non-current assets | 3,816,629 | 3,920,622 |
| Noncurrent assets: | Total assets | 7,213,952 | 9,108,302 |
| Current liabilities: | Accounts payable and accrued liabilities | 1,645,659 | 1,554,243 |
| Current liabilities: | Line of credit |  | 8,109 |
| Current liabilities: | SBA loan, current | 3,614 | 3,595 |
| Current liabilities: | Lease liabilities, current | 375,479 | 371,272 |
| Current liabilities: | Other current liabilities | 30,678 | 41,828 |
| Current liabilities: | Derivative liabilities, current |  | 3,306,745 |
| Current liabilities: | Liability with conditional timing | 450,000 |  |
| Current liabilities: | Loans payable (related party), current | 64,527 | 61,642 |
| Current liabilities: | Loans payable | 267,883 | 402,650 |
| Current liabilities: | Total current liabilities | 2,837,840 | 5,750,084 |
| Non-current liabilities: | Lease liabilities, net of current | 1,340,313 | 1,435,505 |
| Non-current liabilities: | SBA loan, net of current | 135,957 | 136,873 |
| Non-current liabilities: | Convertible note | 837,800 |  |
| Non-current liabilities: | Derivative liabilities, noncurrent | 313,392 |  |
| Non-current liabilities: | Preferred shares liabilities | 6,032,160 |  |
| Non-current liabilities: | Loan payable (related party), net of current | 227,254 | 244,509 |
| Non-current liabilities: | Total non-current liabilities | 8,886,876 | 1,816,887 |
| Non-current liabilities: | Total liabilities | 11,724,716 | 7,566,971 |
| Stockholders’ equity / (deficit) | Series A Preferred stock, par value $0.001 stated value $100, 100,000 shares authorized in 2026 and 2025; 0 and 87,445 shares issued and outstanding, respectively |  | 87 |
| Stockholders’ equity / (deficit) | Series B Preferred stock, par value $0.001 stated value $100, 80,000 authorized in 2026 and 2025; 2,400 and 28,475 shares issued and outstanding, respectively | 2 | 28 |
| Stockholders’ equity / (deficit) | Common stock, $0.00001 par value, 220,000,000 shares authorized, 21,354,686 and 18,704,649 shares outstanding, and 5,190,171 and 0 shares to be issued respectively. | 267 | 187 |
| Stockholders’ equity / (deficit) | Additional paid-in capital | 9,538,131 | 8,522,354 |
| Stockholders’ equity / (deficit) | Accumulated deficit | -14,049,164 | -6,981,325 |
| Stockholders’ equity / (deficit) | Total stockholders’ equity / (deficit) | -4,510,764 | 1,541,331 |
| Stockholders’ equity / (deficit) | Total liabilities and stockholders’ equity / (deficit) | 7,213,952 | 9,108,302 |

### Cash Flow (Three Months Ended — (In U.S. dollars, except share data or otherwise noted))

| | Three Months Ended – March 31, – 2026 | Three Months Ended – March 31, – 2025 |
|---|---:|---:|
| Cash flows from operating activities: | Net loss | -6,990,789 | -126,782 |
| Reconcile net loss to cash provided by operating activities | Allowance for doubtful accounts receivable |  | -1,968 |
| Reconcile net loss to cash provided by operating activities | Allowance for inventory obsolescence |  | 18,464 |
| Reconcile net loss to cash provided by operating activities | Depreciation of property and equipment | 4,582 | 6,225 |
| Reconcile net loss to cash provided by operating activities | Amortization of right-of-use assets | 87,879 | 80,355 |
| Reconcile net loss to cash provided by operating activities | Amortization of intangible assets | 11,532 | 11,532 |
| Reconcile net loss to cash provided by operating activities | Stock-based compensation | 123,288 | 252,905 |
| Reconcile net loss to cash provided by operating activities | Financing expense on warrants |  | 23,138 |
| Reconcile net loss to cash provided by operating activities | Change in fair value of derivative liabilities | -25,374 |  |
| Reconcile net loss to cash provided by operating activities | Loss on issuance of preferred stock | 6,310,464 |  |
| Reconcile net loss to cash provided by operating activities | Dividends | -77,050 |  |
| Changes in operating assets and liabilities: | Accounts receivable | 145,762 | 5,841 |
